Senate Bill 974
115th Congress(2017-2018)
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Introduced
Introduced in Senate on Apr 27, 2017
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
974
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017
This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.
06/21/2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
06/21/2018
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
06/14/2018
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
04/27/2017
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2619)
04/27/2017
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:36:55 PM